Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Neurosci ; 33(27): 10938-49, 2013 Jul 03.
Article in English | MEDLINE | ID: mdl-23825400

ABSTRACT

Working memory is an essential component of higher cognitive function, and its impairment is a core symptom of multiple CNS disorders, including schizophrenia. Neuronal mechanisms supporting working memory under normal conditions have been described and include persistent, high-frequency activity of prefrontal cortical neurons. However, little is known about the molecular and cellular basis of working memory dysfunction in the context of neuropsychiatric disorders. To elucidate synaptic and neuronal mechanisms of working memory dysfunction, we have performed a comprehensive analysis of a mouse model of schizophrenia, the forebrain-specific calcineurin knock-out mouse. Biochemical analyses of cortical tissue from these mice revealed a pronounced hyperphosphorylation of synaptic vesicle cycling proteins known to be necessary for high-frequency synaptic transmission. Examination of the synaptic vesicle cycle in calcineurin-deficient neurons demonstrated an impairment of vesicle release enhancement during periods of intense stimulation. Moreover, brain slice and in vivo electrophysiological analyses showed that loss of calcineurin leads to a gene dose-dependent disruption of high-frequency synaptic transmission and network activity in the PFC, correlating with selective working memory impairment. Finally, we showed that levels of dynamin I, a key presynaptic protein and calcineurin substrate, are significantly reduced in prefrontal cortical samples from schizophrenia patients, extending the disease relevance of our findings. Our data provide support for a model in which impaired synaptic vesicle cycling represents a critical node for disease pathologies underlying the cognitive deficits in schizophrenia.


Subject(s)
Calcineurin/deficiency , Memory Disorders/metabolism , Memory, Short-Term/physiology , Prefrontal Cortex/metabolism , Synaptic Transmission/physiology , Synaptic Vesicles/metabolism , Adult , Animals , Calcineurin/genetics , Female , Humans , Male , Memory Disorders/genetics , Mice , Mice, Knockout , Middle Aged , Nerve Net/metabolism , Organ Culture Techniques , Synaptic Vesicles/genetics
2.
Neurobiol Learn Mem ; 92(1): 106-13, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19368765

ABSTRACT

Dextro-amphetamine enhances memory and other cognitive functions in animals and humans. The use of d-amphetamine as a memory enhancer, however, is limited by a robust stimulatory side-effect profile caused by release of dopamine. The levo enantiomer of amphetamine has been shown to be considerably less effective as a dopamine releaser and less potent in producing the stimulatory effects characteristic of d-amphetamine. In order to determine whether l-amphetamine and the structurally related compound, l-methamphetamine, retain cognitive-enhancing effects despite their lack of stimulatory activity, we administered the compounds to rats prior to activity monitoring experiments, and in different animals, immediately after training on inhibitory avoidance and object recognition tasks. Results demonstrated that l-amphetamine and l-methamphetamine did not increase locomotion and stereotypies beyond control levels, but did produce significant memory enhancement. In addition, l-amphetamine and l-methamphetamine alleviated scopolamine-induced amnesia in the inhibitory avoidance task. In all cases, these compounds produced an effect comparable to that of d-amphetamine, but required only one quarter of the d-amphetamine dose to produce the same effect size. We also found that l-amphetamine modulates learning-induced changes in hippocampal Arc/Arg3.1 protein synthesis that correlate with memory consolidation. These results suggest that l-amphetamine and l-methamphetamine are potent memory enhancers in rats and may ultimately be useful for treating memory disorders in humans.


Subject(s)
Amphetamine/administration & dosage , Central Nervous System Stimulants/administration & dosage , Gene Expression/drug effects , Hippocampus/drug effects , Memory/drug effects , Motor Activity/drug effects , Amnesia/chemically induced , Amnesia/drug therapy , Animals , Avoidance Learning/drug effects , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Dextroamphetamine/administration & dosage , Hippocampus/metabolism , Male , Methamphetamine/administration & dosage , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Rats , Rats, Long-Evans , Recognition, Psychology/drug effects , Scopolamine
3.
Bioorg Med Chem Lett ; 19(12): 3243-6, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19423342

ABSTRACT

Conjugation of the phenol derived from rivastigmine with amphetamines gave access to novel carbamate cholinesterase inhibitors. All compounds possessed increased affinity and selectivity for AChE compared to rivastigmine and were orally bioavailable. Compound 4a, incorporating d-amphetamine, caused significant inhibition of cholinesterase in vivo at doses that were well tolerated. Release of amphetamine from 4a was demonstrated following in vitro and in vivo inhibition of cholinesterase. Compound 4a was also effective in alleviating scopolamine induced amnesia in a rat passive avoidance model.


Subject(s)
Biogenic Amines/metabolism , Carbamates/pharmacology , Cholinesterase Inhibitors/chemistry , Administration, Oral , Amnesia/drug therapy , Amphetamines/chemistry , Animals , Carbamates/chemistry , Cholinesterase Inhibitors/pharmacokinetics , Cholinesterase Inhibitors/pharmacology , Drug Evaluation, Preclinical , Phenylcarbamates/chemistry , Rats , Rivastigmine
4.
J Neurosci ; 24(15): 3826-36, 2004 Apr 14.
Article in English | MEDLINE | ID: mdl-15084664

ABSTRACT

Spatial and contextual learning are considered to be dependent on the hippocampus, but the extent to which other structures in the medial temporal lobe memory system support these functions is not well understood. This study examined the effects of individual and combined lesions of the perirhinal, postrhinal, and entorhinal cortices on spatial and contextual learning. Lesioned subjects were consistently impaired on measures of contextual fear learning and consistently unimpaired on spatial learning in the Morris water maze. Neurotoxic lesions of perirhinal or postrhinal cortex that were previously shown to impair contextual fear conditioning (Bucci et al., 2000) or contextual discrimination (Bucci et al., 2002) caused little or no impairment in place learning and incidental learning in the water maze. Combined lesions of perirhinal plus lateral entorhinal or postrhinal plus medial entorhinal cortices resulted in deficits in acquisition of contextual discrimination but had no effect on place learning in the water maze. Finally, a parahippocampal lesion comprising combined neurotoxic damage to perirhinal, postrhinal, and entorhinal cortices resulted in profound impairment in acquisition of a standard passive avoidance task but failed to impair place learning. In the same experiment, rats with hippocampal lesions were impaired in spatial navigation. These results indicate that tasks requiring the association between context and an aversive stimulus depend on corticohippocampal circuitry, whereas place learning in the water maze can be accomplished without the full complement of highly processed information from the cortical regions surrounding the hippocampus. The evidence that different brain systems underlie spatial navigation and contextual learning has implications for research on memory when parahippocampal regions are involved.


Subject(s)
Cerebral Cortex/physiology , Hippocampus/physiology , Learning/physiology , Maze Learning/physiology , Animals , Avoidance Learning/physiology , Behavior, Animal/physiology , Conditioning, Psychological , Discrimination Learning/physiology , Entorhinal Cortex/physiology , Fear/physiology , Male , Parahippocampal Gyrus/physiology , Rats , Rats, Long-Evans , Reaction Time/physiology
SELECTION OF CITATIONS
SEARCH DETAIL